ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

COSM vs NUS // 10Y YIELD & FRED MACRO BETA

Cosmos Health Inc. (NASDAQ) VS. Nu Skin Enterprises Inc. (NYSE) • 15-METRIC TALLY: COSM 2 — NUS 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COSM VS. NUS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC COSM NUS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 12.10% 69.40% -57.30 NUS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 6.70% -41.70 NUS /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — 20.15% — TIE /fcf-yield <GO>
Operating Margin -25.60% 4.40% -30.00 NUS /operating-margins <GO>
Net Profit Margin -29.30% 10.80% -40.10 NUS /net-margins <GO>
Revenue Growth (YoY) 19.90% -14.30% +34.20 COSM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 5.18% -5.18 NUS /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 3.54 -3.34 NUS /balance-sheet <GO>
Piotroski F-Score Quality 3/9 7/9 -4.00 NUS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.5 43.2 +8.37 COSM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $27.9M $228.3M -$200.4M NUS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR COSM REV NUS REV COSM GROSS % NUS GROSS % COSM FCF NUS FCF
FY 2025 $65.3M $1.49B 12.1% 69.4% -$8.5M $46.0M
FY 2024 $54.4M $1.73B 7.9% 68.2% -$8.1M $70.2M
FY 2023 $53.4M $1.97B — — -$15.6M $118.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COSM // BETA —
NUS // BETA —